Piscidins — antimicrobial peptides found exclusively in bony fish — kill both types of bacteria, remain stable in salty conditions, and could inspire new treatments for drug-resistant infections.
Salt-stable AMPsUnlike most antimicrobial peptides that lose activity in salty conditions, piscidins remain effective in high-salt environments — a critical advantage for therapeutic development
What the researchers found
Bioinformatics analysis of all reviewed piscidin sequences in the UniProt database revealed that these fish-exclusive antimicrobial peptides share amphipathic alpha-helical structures with positively charged residues that drive their antibacterial activity. Piscidins are effective against both Gram-positive and Gram-negative bacteria that cause disease in fish and humans.
A key advantage is their stability in high-salt and metal-rich environments — conditions that disable many other antimicrobial peptides. The study identified potential applications beyond antibiotics, including anti-cancer and anti-inflammatory uses, and suggests piscidins could inspire treatments for multidrug-resistant bacterial infections.
Why it matters
With antibiotic resistance rising globally, scientists are searching nature for new antimicrobial compounds. Piscidins represent a unique class of antimicrobial peptides found only in bony fish, shaped by millions of years of evolution in microbe-rich aquatic environments. Their stability in salt water — where most other AMPs lose function — makes them particularly interesting for development as therapeutic agents, since salt tolerance has been a major limitation of other antimicrobial peptides in clinical settings.
The numbers in context
Exclusive to Teleost fish · Effective against Gram-positive and Gram-negative bacteria · Amphipathic alpha-helical structure · Stable in high-salt environments · Broader spectrum than conventional antibiotics
How the study worked
Comprehensive bioinformatics analysis of all piscidin sequences in the 'reviewed' category of the UniProt protein database. The authors used computational tools to analyze structural properties, amphipathic architecture, charge distribution, and predicted biological activities. The study also synthesized published experimental data on piscidin bioactivity.
Who was studied
Bioinformatics analysis of piscidin peptide sequences from the UniProt database
What this study cannot tell us
This is primarily a computational (in silico) and literature review study. Bioinformatics predictions of antimicrobial activity need experimental validation. The study does not present new laboratory or clinical data on piscidin efficacy. Translation from fish immune peptides to human therapeutics would require extensive pharmacological development including toxicity testing, stability optimization, and delivery system development.
How to read the evidence
This is a bioinformatics (computational) study combined with literature review. It provides structural and predicted functional analysis but no new experimental data. Predictions require laboratory and clinical validation.
When this study was published
Published in 2023, this study provides a current computational overview of the piscidin peptide family. The field of antimicrobial peptide drug development is actively evolving.
The bigger picture
The antimicrobial resistance crisis has intensified the search for new antibiotic classes. Antimicrobial peptides from nature represent a vast, largely untapped resource. Piscidins are particularly interesting because fish have evolved in environments teeming with microbes, and these peptides have been refined over hundreds of millions of years of evolution. Their salt stability addresses a key limitation that has hampered clinical development of other antimicrobial peptides.
Questions still open
- Can piscidin peptides be modified for optimal therapeutic use while retaining their salt-stable antimicrobial activity?
- What are the toxicity profiles of piscidins in mammalian systems?
- Could piscidin-inspired peptides be effective against the WHO's priority list of antibiotic-resistant pathogens?
Common questions
What makes fish antimicrobial peptides different from other natural antibiotics?
Could piscidins really become new antibiotics for humans?
Read the original research
Teleost Piscidins-In Silico Perspective of Natural Peptide Antibiotics from Marine Sources.
Antibiotics (Basel, Switzerland), 12(5)
Citation
Asensio-Calavia, Patricia; González-Acosta, Sergio; Otazo-Pérez, Andrea; López, Manuel R; Morales-delaNuez, Antonio; Pérez de la Lastra, José Manuel. (2023). Teleost Piscidins-In Silico Perspective of Natural Peptide Antibiotics from Marine Sources.. Antibiotics (Basel, Switzerland), 12(5). https://doi.org/10.3390/antibiotics12050855